Skip to main content
ISTH 2023 Main banner
Back

    Michiel Coppens, MD, PhD (he/him/his)

    Medical Specialist
    Amsterdam University Medical Centers, Amsterdam, The Netherlands
    Amsterdam, Noord-Holland, Netherlands

    Dr Michiel Coppens works as an internist in vascular medicine and hemophilia at the Amsterdam University Medical Centers (UMC). He obtained a PhD in Medicine under supervision of Harry Büller and Saskia Middeldorp on studies on (testing for) inherited thrombophilia. In 2012 Michiel joined of the Haemophilia Treatment Center of the Amsterdam UMC, of which he currently is the acting head. In hemophilia research, he mainly collaborates with Karin Fijn van Draat, Samantha Gouw and other Dutch hemophilia doctors. His main focus is on gene therapy. In 2015 he was the first to treat a person with hemophilia with gene therapy in the Netherlands and has collectively now dosed 9 patients across multiple trials in hemophilia A and B. He is a member of the working group on Gene Therapy of the European Association for Haemophilia and Allied Disorders (EAHAD) and he is the chair of the working group on Thrombosis & Haemostasis of the NVIVG (Dutch Society for Internists Vascular Medicine). He is an author on over 100 peer-reviewed publications.

    Presentation(s):